EUROAPI announced that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key veterinary product. The total contract value is expected to range between EUR 130 million and 150 million, over the 2025-2029 period.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 EUR | -4.02% |
|
-3.19% | -49.21% |
06-18 | Euroapi: CDMO agreement with Priothera in oncology | CF |
06-07 | EuroAPI appoints mediator to help restructure pile of debt, shares drop | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.21% | 309M | |
+51.63% | 796B | |
+40.83% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.36% | 244B | |
+4.01% | 228B | |
+12.83% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- EAPI Stock
- News EUROAPI
- EUROAPI Enters into Contract Manufacturing Organization Agreement with Global Animal Health Company